SCIESCOPUSQ3
IN VIVO
INT INST ANTICANCER RESEARCH, Greece
IN VIVO is an academic journal published by INT INST ANTICANCER RESEARCH (Greece). Identifiers: ISSN 0258-851X, eISSN 1791-7549. Indexed in SCIE, SCOPUS. Metrics: JIF 1.8, CiteScore 3.5, SJR 0.562, SNIP 0.74. Subject areas: MEDICINE, MEDICINE, RESEARCH & EXPERIMENTAL, RESEARCH & EXPERIMENTAL. tlooto lists 7,325 papers from this journal.
CiteScore
3.50
Scopus citation metric
SJR
0.562
SCImago rank
SNIP
0.74
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 0258-851X
- eISSN
- 1791-7549
- Abbreviation
- IN VIVO
- Publisher
- INT INST ANTICANCER RESEARCH
- Country
- Greece
Web of Science categories
SCIEMEDICINE, RESEARCH & EXPERIMENTAL
Scopus ASJC categories
1300 General Biochemistry1306 Cancer Research3004 Pharmacology
Keywords
Medicine, Research & Experimental
Papers in this journal
Recent papers
- Diurnal and Daily Variations in Growth Hormone and Growth Hormone Stimulation Test in Male Cynomolgus Monkeys
2026
- Male Sex as a Risk Factor for Perioperative Morbidity and Recurrence Following Minimally Invasive Distal Gastrectomy for Gastric Cancer: A Propensity Score Matching Analysis
2026
- Effects of a Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin on Pancreas in Obese Diabetic Mice
2026
- Ultra-low Concentrations of Cisplatinum Down to the IC10 in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo
2026
- Prurigo Nodularis Increases Risk of Non-alcoholic Fatty Liver Disease and Liver Cirrhosis: A Global-federated Retrospective Cohort Study
2026
Most cited papers
- Gamma-H2AX - a novel biomarker for DNA double-strand breaks.
2008 · 827 citations
- γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks
2008 · 807 citations
- The antitumor activities of flavonoids.
2005 · 687 citations
- Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification.
2014 · 666 citations
- High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases.
1994 · 613 citations